Clinical Edge Journal Scan

Commentary: Gastric Cancer Chemotherapy in Select Populations, June 2022

Author and Disclosure Information

 

Additional References

1. Hwang IG, Ji JH, Kang JH, et al. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. J Geriatr Oncol. 2017;8(3):170-175. Doi: 10.1016/j.jgo.2017.01.002

2. Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358:36-46. Doi: 10.1056/NEJMoa073149

Pages

Recommended Reading

Survival after CRS-HIPEC in synchronous vs metachronous peritoneal metastasis of CRC
MDedge Hematology and Oncology
Can proximal serrated polyp detection rate serve as an indicator for interval post-colonoscopy CRC?
MDedge Hematology and Oncology
Can proximal serrated polyp detection rate serve as an indicator for interval post-colonoscopy CRC?
MDedge Hematology and Oncology
Evidence supporting initiation of CRC screening before 50 years of age in women
MDedge Hematology and Oncology
KRAS p.G12C mutations may have prognostic implications in mCRC
MDedge Hematology and Oncology
ctDNA: Strong prognostic biomarker but lacks true clinical utility in mCRC
MDedge Hematology and Oncology
ctDNA: Strong prognostic biomarker but lacks true clinical utility in mCRC
MDedge Hematology and Oncology
Sugar-sweetened beverage and sugar consumption tied with incidence of and mortality from proximal colon cancer
MDedge Hematology and Oncology
Case study: Managing venous thromboembolism in the cancer patient
MDedge Hematology and Oncology
Immunotherapy now first line for esophageal cancer
MDedge Hematology and Oncology